China International Capital Corp Ltd top stories

• China’s Broad Homes plots Hong Kong listing

  

  Mainland firm Changsha Broad Homes Industrial Group has set the ball rolling for a Hong Kong IPO, submitting a draft prospectus to the bourse.

  • 18 Jan 2019

• Yield-hungry investors buoy property bonds

  The party in Chinese high yield real estate bonds continued this week, with China Aoyuan Group, Zhenro Properties and Yuzhou Properties taking home $1.15bn between them on Tuesday.

  • 16 Jan 2019

• BoCom Leasing adds $1.5bn to coffers with first 2019 bond

  China’s Bank of Communications Financial Leasing Co managed to raise the upper end of its $1.5bn target size at a tighter-than-expected level on Tuesday, a feat achieved despite a busy bond market in Asia.

  • 16 Jan 2019

• Weimob prices IPO low to rake in $108m

  Tencent Holdings-backed Weimob raised HK$845m ($107.8m) after pricing its IPO at the bottom of the indicative range on Thursday, a bit behind the original schedule, according to a banker close to the deal.

  • 11 Jan 2019

• Chengdu Expressway IPO flickers amid dull HK market

  Chengdu Expressway Co’s HK$880m ($112.3m) IPO has marked the start of a quiet week for the Hong Kong equity capital markets.

  • 07 Jan 2019

• Weimob woos investors to $135m HK IPO

  Considerably cheap valuations have made Weimob, a Tencent Holdings-backed company that is on the road with its Hong Kong IPO, an attractive proposition for equity investors, according to a source close to the listing.

  • 02 Jan 2019

• CIMC Vehicles revs up $500m Hong Kong IPO

  CIMC Vehicles Co is eyeing $500m from a Hong Kong IPO, with plans to launch the listing by the end of the first quarter, according to a source close to the deal.

  • 02 Jan 2019

• Wuhan LGFV debuts with club-style bond

  Wuhan Financial Holdings Group Co made its dollar market debut on Monday, raising $142m from a three year club-style deal.

  • 18 Dec 2018

• Fosun plans $800m Henlius Biotech spin-off

  Shanghai Henlius Biotech has joined a growing pipeline of biotechnology firms planning to float in Hong Kong. It wants to list in the first quarter of 2019, said a banker working on the transaction.

  • 17 Dec 2018

• Junshi Bio seals $394m Hong Kong IPO

  Shanghai Junshi Biosciences has raised HK$3.08bn ($394.2m) after pricing its IPO at the bottom of the range, according to a banker on the deal.

  • 17 Dec 2018